Inhaled Caffeine Under Investigation

By: Mahdieh Danesh Yazdi

A few months ago, a new product called AeroShot Pure Energy hit the markets in New York and Massachusetts.  AeroShot is a new inhaler that gives the user bursts of caffeine.  Each inhaler contains an estimated 100mg of caffeine, approximately the same amount as a large cup of coffee.  It also contains B-vitamins, sweeteners, natural lime flavor, citric acid, and sodium bicarbonate.  It was developed by Harvard professor of biomedical engineering, David Edwards, the same individual responsible for the chocolate inhaler, LeWhif (indeed, chocolate also is available as an inhalation). Breathable Foods Inc. is currently marketing the product.

Each inhaler contains about 4-6 puffs, and each puff translates into roughly 15-25 mg of caffeine.  The packaging of the product recommends that use be limited to three puffs daily.  The manufacturer boasts that AeroShot offers the benefits of caffeine in a convenient and calorie-free manner.  The FDA has not approved the product as it is as a “dietary supplement.”

Recently, Sen. Chuck Schumer (D-NY) has asked the FDA to conduct an investigation into the safety of AeroShot.  The commissioner of the FDA, Dr. Margaret Hamburg, has agreed to do the investigation and the manufacturer has promised to fully cooperate with the FDA.  Sen. Schumer expressed concern over the possibility that consumers may abuse the product, using dangerously high levels to stay awake as long as possible.  These fears are similar to those expressed over alcoholic drinks that were also caffeinated.  These drinks, such as Four Loko, have since been banned.  The senator also stated that the packaging of the product claims that is safe for ages 12 and up, but that the American Academy of Pediatrics has previously reported variable and dose-dependent effects of caffeine on children.  The manufacturer claims that it does not recommend the use of the product in those under 18 and does not market it to children.

We have yet to see if the FDA’s investigations will lead to any serious consequences for the marketing of AeroShot.

SOURCES:

  1. Breathable Foods, Inc. AeroShot Energy. 2012. 26 February 2012 <http://www.aeroshots.com/?>.
  2. WKBW News. Schumer Calls for Review of Caffeine Inhaler. 19 February 2012. 26 February 2012 <http://www.msnbc.msn.com/id/46449719/ns/local_news-buffalo_ny/t/schumer-calls-review-caffeine-inhaler/#.T1DhHofOU1M>
eMAR

Recent Posts

Oxidative Stress and Its Impact on Vitiligo

By: Zurriya Faran, PharmD Candidate c/o 2031 The visible loss of skin pigmentation often indicates…

2 months ago

Thiamine Metabolic Dysfunction Syndrome: Overview, importance, MOA, and treatment

By: Archana Murugan, PharmD candidate c/o 2029 Overview             Thiamine metabolic dysfunction syndrome (TMDS) refers…

2 months ago

Updated Guidelines for the Treatment of Multidrug and Rifampin-Resistant TB and Promising New Anti-TB Drugs in Phase 2/3 Trials

By: Kevin Lee, PharmD Candidate c/o 2028, Angela Yin, PharmD Candidate c/o 2028             The…

2 months ago

Sixth Year Perspective: Interview with Ariella Zadrima, PharmD Candidate, c/o 2026

By: Aymon Choudhury, PharmD Candidate c/o 2027 APPE questions: How did your APPE rotations shape…

2 months ago

Foundayo: The New Drug in the GLP-1 market

By: Sariah Grant, PharmD Candidate c/o 2027             The rise of glucagon-like peptide -1 receptor…

2 months ago

Should All Drugs be OTC? Risks and Consequences of the FDA Commissioner Statement

By: Amanda Kastel, PharmD Candidate c/o 2027 In February 2026, FDA Commissioner Marty Makary stated…

2 months ago